FLI1 and B-cell non-Hodgkin lymphoma: A661 and A665 induced differentiation and apoptosis and attenuated the growth of B-cell lymphomas expressing high levels of Fli-1 in vitro, and erythroleukemia in a preclinical model in vivo.